PARK2 antibody (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin)) (AA 387-417)

Details for Product anti-PARK2 Antibody No. ABIN390366, Supplier: Log in to see
Antigen
  • CG10523
  • Dmel\\CG10523
  • Dpark
  • SD01679
  • dpk
  • si:ch211-123f21.1
  • zgc:112390
  • LOC100150461
  • PRKN
  • Park
  • Prkn
  • AR-JP
  • LPRS2
  • PDJ
  • pdr-1
  • parkin
  • Parkinson disease (autosomal recessive, juvenile) 2, parkin
  • parkinson protein 2, E3 ubiquitin protein ligase (parkin)
  • parkinson protein 2, E3 ubiquitin protein ligase
  • park
  • park2
  • PARK2
  • CpipJ_CPIJ014867
  • LOC100150461
  • Park2
Epitope
AA 387-417, C-Term
24
24
21
12
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine)
173
49
41
9
6
3
3
2
1
1
Host
Rabbit
163
10
6
Clonality (Clone)
Polyclonal ()
Conjugate
This PARK2 antibody is un-conjugated
5
5
4
3
3
3
3
3
3
3
3
3
3
3
Application
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
124
53
52
39
26
21
13
8
6
4
2
2
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Immunogen This Parkin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 387-417 AA from the C-terminal region of human Parkin.
Clone RB07373
Isotype Ig
Specificity This Parkin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 395~425 amino acids from the C-terminal region of human Park2.
Purification This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Alternative Name Parkin (PARK2 Antibody Abstract)
Background Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. The function of Park2 is not well-known, however, it may play a role in the ubiquitin-mediated proteolytic pathway. Mutations in this gene are known to cause autosomal recessive juvenile parkinsonism. Alternative splicing of this gene produces three known products of undetermined function.
Synonyms: Parkin isoform 1, Parkin, E3 ubiquitin ligase, Ubiquitin E3 ligase PRKN, Parkinson juvenile disease protein 2, Parkinson disease protein 2, PRKN, Park2
Molecular Weight 51651 DA
Gene ID 5071
NCBI Accession NP_004553
Research Area Phospho-specific antibodies, Cell Signaling, Protein Modifications, Neurology, Cell Structure
Application Notes WB = 1:1000, IF = 1:10-50, FACS = 1:10-50, IHC (p) = 1:50-100
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Western Blotting (WB) image for anti-Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (AA 387-417), (C-Term) antibody (ABIN390366) The anti-Parkin C-term Pab (ABIN390366) is used in Western blot to detect Parkin in m...
Immunohistochemistry (IHC) image for anti-Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (AA 387-417), (C-Term) antibody (ABIN390366) Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary ant...
Immunohistochemistry (IHC) image for anti-Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (AA 387-417), (C-Term) antibody (ABIN390366) Formalin-fixed and paraffin-embedded human testis tissue reacted with PARK2 (Parkin) ...
Background publications West, Kapatos, OFarrell, Gonzalez-de-Chavez, Chiu, Farrer, Maidment: "N-myc regulates parkin expression." in: The Journal of biological chemistry, Vol. 279, Issue 28, pp. 28896-902, 2004 (PubMed).

Wang, Denison, Lai, Philips, Montoya, Kock, Schüle, Klein, Shridhar, Roberts, Smith: "Parkin gene alterations in hepatocellular carcinoma." in: Genes, chromosomes & cancer, Vol. 40, Issue 2, pp. 85-96, 2004 (PubMed).

Did you look for something else?